Iben Kümler

Iben Kümler serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical oncology work is based at Blegdamsvej 3, 2200 Copenhagen N, Denmark, with institutional affiliation through the Capital Region of Denmark (Region Hovedstaden).

Her research concentrates on real-world clinical outcomes in breast cancer subtypes, particularly:

• Metastatic HR+/HER2- breast cancer treatment with CDK4/6 inhibitors like palbociclib
• HER2-positive disease management including trastuzumab adjuvant therapy
• Triple-negative metastatic cancer targeted treatments
• Nationwide Danish registry studies on incidence, survival, and screening implications
• Real-world effectiveness of capecitabine and other chemotherapies

Analysis of her 2023-2025 publications reveals consistent methodological focus on nationwide retrospective studies leveraging Denmark's comprehensive cancer registries, with strong emphasis on treatment sequencing in heavily pretreated patients and subtype-specific therapeutic outcomes across 8 major publications.

Scientific awards:

• No awards documented in provided materials

Advising and grants:

• No student mentorship or grant funding details specified

Labs and teams:

• Collaborates with Danish Breast Cancer Cooperative Group (DBCG) networks
• Works within University of Copenhagen's clinical oncology research environment
• Engages in multi-institutional nationwide studies across Danish hospitals